Cargando…
GLP-2 Improves Hepatic Inflammation and Fibrosis in Mdr2(-/-) Mice Via Activation of NR4a1/Nur77 in Hepatic Stellate Cells and Intestinal FXR Signaling
BACKGROUND & AIMS: Glucagon-like peptide (GLP)-2 may exert antifibrotic effects on hepatic stellate cells (HSCs). Thus, we aimed to test whether application of the GLP-2 analogue teduglutide has hepatoprotective and antifibrotic effects in the Mdr2/Abcb4(-/-) mouse model of sclerosing cholangiti...
Autores principales: | Fuchs, Claudia D., Claudel, Thierry, Mlitz, Veronika, Riva, Alessandra, Menz, Moritz, Brusilovskaya, Ksenia, Haller, Felix, Baumgartner, Maximilian, Königshofer, Philipp, Unger, Lukas W., Sjöland, Wilhelm, Scharnagl, Hubert, Stojakovic, Tatjana, Busslinger, Georg, Reiberger, Thomas, Marschall, Hanns-Ulrich, Trauner, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522987/ https://www.ncbi.nlm.nih.gov/pubmed/37572734 http://dx.doi.org/10.1016/j.jcmgh.2023.08.003 |
Ejemplares similares
-
FXR controls CHOP expression in steatohepatitis
por: Fuchs, Claudia D., et al.
Publicado: (2017) -
Absence of Bsep/Abcb11 attenuates MCD diet‐induced hepatic steatosis but aggravates inflammation in mice
por: Fuchs, Claudia D., et al.
Publicado: (2020) -
The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model
por: Schwabl, Philipp, et al.
Publicado: (2021) -
Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2(−/−)
mouse model of sclerosing cholangitis via immunomodulatory effects
por: Fuchs, Claudia D., et al.
Publicado: (2022) -
Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2(-/-) mouse model of sclerosing cholangitis
por: Fuchs, Claudia D., et al.
Publicado: (2023)